1. Gummert JF, Funkat AK, Beckmann A, Ernst M, Hekmat K, Beyersdorf F, Schiller W. Cardiac surgery in germany during 2010: A report on behalf of the german society for thoracic and cardiovascular surgery. The Thoracic and cardiovascular surgeon. 2011;59:259-267
2. Haverich A. Herzklappenchirurgie. Altersverteilung und Sterblichkeit.
Jahresbericht 2008/2009, Herz-, Thorax-, Transplantations- und Gefäßchirurgie, Medizinische Hochschule Hannover. 2009
3. Haverich A. Herzklappenchirurgie. Altersverteilung und Sterblichkeit.
Jahresbericht 2011, Herz-, Thorax-, Transplantations- und Gefäßchirurgie, Medizinische Hochschule Hannover. 2012
4. Kaemmerer H, Hess J. [congenital heart disease. Transition from adolescence to adulthood]. Der Internist. 2009;50:1221-1222, 1224-1227
5. Barili F, Dainese L, Cheema FH, Argenziano M, Locatelli A, Grossi C.
Bioengineering of the aortic valve: A race without a finish line. Artificial organs.
2009;33:86-87
6. Felsch M. Angeborene Herzfehler im Erwachsenenalter. Der Internist.
2009:1221-1228
7. H. G. Herzklappenerkrankungen. Kompendium der kardiologischen Prävention und Rehabilitation. 2009:53-65
8. Nickel R., Schummer A., Seiferle E. Herzkammern. Lehrbuch der Anatomie der Haustiere, Band III: Kreislaufsystem, Haut und Hautorgane hg. von
Habermehl K., Vollmerhaus B., Wilkens H., Waibl H., Parey Buchverlag Berlin.
1996; 3.Auflage: 30-36
9. Harmeyer J. Vorgänge der Kammerfüllung und -entleerung. Physiologie der Haustiere hg. von Engelhardt von W., Breves G., Enke Verlag Stuttgart. 2005;
2. Auflage:139-141
10. Gray´s anatomy of the human body. 1918
11. Misfeld M, Sievers HH. Heart valve macro- and microstructure. Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
2007;362:1421-1436
12. Perrotta I. Ultrastructural features of human atherosclerosis. Ultrastructural pathology. 2013;37:43-51
13. Fujiwara NH, Kallmes DF, Li ST, Lin HB, Hagspiel KD. Type 1 collagen as an endovascular stent-graft material for small-diameter vessels: A biocompatibility study. Journal of vascular and interventional radiology : JVIR. 2005;16:1229-1236
14. Cole WG, Chan D, Hickey AJ, Wilcken DE. Collagen composition of normal and myxomatous human mitral heart valves. The Biochemical journal.
1984;219:451-460
15. Liebich H-G. Wandbau größerer Gefäße. Funktionelle Histologie der Haussäugetiere. Schattauer Verlag Stuttgart. 2004; 4. Auflage: 133-139
16. Sacks MS, Yoganathan AP. Heart valve function: A biomechanical perspective. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2007;362:1369-1391
17. Hinton RB, Jr., Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circulation research. 2006;98:1431-1438
18. Maron BJ, Hutchins GM. The development of the semilunar valves in the human heart. The American journal of pathology. 1974;74:331-344
19. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. Vegf guides angiogenic sprouting utilizing endothelial tip cell filopodia. The Journal of cell biology.
2003;161:1163-1177
20. Marron K, Yacoub MH, Polak JM, Sheppard MN, Fagan D, Whitehead BF, de Leval MR, Anderson RH, Wharton J. Innervation of human atrioventricular and arterial valves. Circulation. 1996;94:368-375
21. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. The international journal of biochemistry & cell biology.
2003;35:113-118
22. Huber D, Cramer EM, Kaufmann JE, Meda P, Masse JM, Kruithof EK, Vischer UM. Tissue-type plasminogen activator (t-pa) is stored in weibel-palade bodies in human endothelial cells both in vitro and in vivo. Blood. 2002;99:3637-3645
23. Kim J, Jeon YJ, Kim HE, Shin JM, Chung HM, Chae JI. Comparative proteomic analysis of endothelial cells progenitor cells derived from cord blood- and peripheral blood for cell therapy. Biomaterials. 2013;34:1669-1685
24. Iwakiri Y, Satoh A, Chatterjee S, Toomre DK, Chalouni CM, Fulton D, Groszmann RJ, Shah VH, Sessa WC. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein s-nitrosylation and protein trafficking. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:19777-19782
25. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. The Journal of cell biology. 1992;118:1511-1522
26. Gulino D, Delachanal E, Concord E, Genoux Y, Morand B, Valiron MO, Sulpice E, Scaife R, Alemany M, Vernet T. Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. The Journal of biological chemistry. 1998;273:29786-29793
27. Reis RM, Reis-Filho JS, Longatto Filho A, Tomarev S, Silva P, Lopes JM.
Differential prox-1 and cd 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors. Pathology, research and practice.
2005;201:771-776
28. Yusuf B, Gopurappilly R, Dadheech N, Gupta S, Bhonde R, Pal R. Embryonic fibroblasts represent a connecting link between mesenchymal and embryonic stem cells. Development, growth & differentiation. 2013
29. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001;104:2525-2532
30. Wu S, Liu YL, Cui B, Qu XH, Chen GQ. Study on decellularized porcine aortic valve/poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) hybrid heart valve in sheep model. Artificial organs. 2007;31:689-697
31. Honge JL, Funder J, Hansen E, Dohmen PM, Konertz W, Hasenkam JM.
Recellularization of aortic valves in pigs. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2011;39:829-834
32. Bajpai VK, Mistriotis P, Loh YH, Daley GQ, Andreadis ST. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via
mesenchymal stem cell intermediates. Cardiovascular research. 2012;96:391-400
33. Dabbagh K, Laurent GJ, McAnulty RJ, Chambers RC. Thrombin stimulates smooth muscle cell procollagen synthesis and mrna levels via a par-1 mediated mechanism. Thrombosis and haemostasis. 1998;79:405-409
34. Song YC, Yao LY, Kneebone JM, Lupinetti FM. Effect of cryopreservation and histocompatibility on type i procollagen gene expression in aortic valve grafts.
The Journal of thoracic and cardiovascular surgery. 1997;114:421-427
35. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue.
Circulation. 2000;102:III50-55
36. Lichtenberg A, Tudorache I, Cebotari S, Suprunov M, Tudorache G, Goerler H, Park JK, Hilfiker-Kleiner D, Ringes-Lichtenberg S, Karck M, Brandes G, Hilfiker A, Haverich A. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation.
2006;114:I559-565
37. Lupinetti FM, Kneebone JM, Rekhter MD, Brockbank KG, Gordon D.
Procollagen production in fresh and cryopreserved aortic valve grafts. The Journal of thoracic and cardiovascular surgery. 1997;113:102-107
38. Pibarot P, Dumesnil JG. Prosthetic heart valves: Selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034-1048
39. Vesely I. Heart valve tissue engineering. Circulation research. 2005;97:743-755
40. Sharma S, Mehra A, Rahimtoola SH. Valvular heart disease: A century of progress. The American journal of medicine. 2008;121:664-673
41. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. The New England journal of medicine. 1996;335:407-416
42. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: Its production and regulation. The International journal of artificial organs.
2005;28:1062-1068
43. Ozdogan ME, Oktar L, Gunaydin S, Halit V, Sinav A, Yener A, Ersoz A. Mitral and aortic valve replacement using fresh unstented pulmonary and aortic homografts. The Journal of heart valve disease. 1996;5:181-185
44. Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. The Annals of thoracic surgery. 2001;71:S385-388
45. Magilligan DJ, Jr., Lewis JW, Jr., Tilley B, Peterson E. The porcine bioprosthetic valve. Twelve years later. The Journal of thoracic and cardiovascular surgery. 1985;89:499-507
46. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the veterans affairs randomized trial. Journal of the American College of Cardiology.
2000;36:1152-1158
47. Umashankar PR, Mohanan PV, Kumari TV. Glutaraldehyde treatment elicits toxic response compared to decellularization in bovine pericardium.
Toxicology international. 2012;19:51-58
48. Huang G, Rahimtoola SH. Prosthetic heart valve. Circulation. 2011;123:2602-2605
49. Rippel RA, Ghanbari H, Seifalian AM. Tissue-engineered heart valve: Future of cardiac surgery. World journal of surgery. 2012;36:1581-1591
50. Hutmacher DW, Goh JC, Teoh SH. An introduction to biodegradable materials for tissue engineering applications. Annals of the Academy of Medicine, Singapore. 2001;30:183-191
51. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, Wolner E, Simon P, Weigel G. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation. 2005;111:2792-2797
52. Xiong Y, Chan WY, Chua AW, Feng J, Gopal P, Ong YS, Song C.
Decellularized porcine saphenous artery for small-diameter tissue-engineered conduit graft. Artificial organs. 2013
53. Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, Lichtenberg A, Cheptanaru E, Barnaciuc S, Cazacu A, Maliga O, Repin O, Maniuc L, Breymann T, Haverich A. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: Early report. Circulation. 2011;124:S115-123
54. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA.
Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nature medicine. 2008;14:213-221
55. Schwarz S, Koerber L, Elsaesser AF, Goldberg-Bockhorn E, Seitz AM, Durselen L, Ignatius A, Walther P, Breiter R, Rotter N. Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications.
Tissue engineering. Part A. 2012;18:2195-2209
56. Wainwright DJ. Use of an acellular allograft dermal matrix (alloderm) in the management of full-thickness burns. Burns : journal of the International Society for Burn Injuries. 1995;21:243-248
57. Sullivan DC, Mirmalek-Sani SH, Deegan DB, Baptista PM, Aboushwareb T, Atala A, Yoo JJ. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials. 2012;33:7756-7764
58. Song JJ, Ott HC. Organ engineering based on decellularized matrix scaffolds.
Trends in molecular medicine. 2011;17:424-432
59. Malone JM, Brendel K, Duhamel RC, Reinert RL. Detergent-extracted small-diameter vascular prostheses. Journal of vascular surgery. 1984;1:181-191
60. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. The Annals of thoracic surgery. 1995;60:S353-358
61. Baraki H, Tudorache I, Braun M, Hoffler K, Gorler A, Lichtenberg A, Bara C, Calistru A, Brandes G, Hewicker-Trautwein M, Hilfiker A, Haverich A, Cebotari S. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials. 2009;30:6240-6246
62. McBane JE, Sharifpoor S, Labow RS, Ruel M, Suuronen EJ, Santerre JP.
Tissue engineering a small diameter vessel substitute: Engineering constructs with select biomaterials and cells. Current vascular pharmacology.
2012;10:347-360
63. Lichtenberg A, Tudorache I, Cebotari S, Ringes-Lichtenberg S, Sturz G, Hoeffler K, Hurscheler C, Brandes G, Hilfiker A, Haverich A. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials. 2006;27:4221-4229
64. Lichtenberg A, Cebotari S, Tudorache I, Sturz G, Winterhalter M, Hilfiker A, Haverich A. Flow-dependent re-endothelialization of tissue-engineered heart valves. The Journal of heart valve disease. 2006;15:287-293; discussion 293-284
65. Flanagan TC, Sachweh JS, Frese J, Schnoring H, Gronloh N, Koch S, Tolba RH, Schmitz-Rode T, Jockenhoevel S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue engineering. Part A. 2009;15:2965-2976
66. Robinson PS, Johnson SL, Evans MC, Barocas VH, Tranquillo RT. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue engineering. Part A. 2008;14:83-95
67. Fischlein T, Lehner G, Lante W, Fittkau M, Murphy JG, Weinhold C, Reichart B. Endothelialization of cardiac valve bioprostheses. The International journal of artificial organs. 1994;17:345-352
68. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, Dudczak R, Lugmaier H, Schmidt P, Noszian I, et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: An actuarial follow-up over three years. Journal of vascular surgery. 1994;19:540-548
69. Bordenave L, Remy-Zolghadri M, Fernandez P, Bareille R, Midy D. Clinical performance of vascular grafts lined with endothelial cells. Endothelium : journal of endothelial cell research. 1999;6:267-275
70. Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von willebrand factor from human endothelial cells. Blood. 2008;112:957-964
71. Metcalf DJ, Nightingale TD, Zenner HL, Lui-Roberts WW, Cutler DF.
Formation and function of weibel-palade bodies. Journal of cell science.
2008;121:19-27
72. Waldman SA, Murad F. Biochemical mechanisms underlying vascular smooth muscle relaxation: The guanylate cyclase-cyclic gmp system. Journal of cardiovascular pharmacology. 1988;12 Suppl 5:S115-118
73. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. Journal of leukocyte biology. 1993;54:171-178
74. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by plgf treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-flt1.
Nature medicine. 2002;8:831-840
75. Itoh Y, Toriumi H, Yamada S, Hoshino H, Suzuki N. Resident endothelial cells surrounding damaged arterial endothelium reendothelialize the lesion.
Arteriosclerosis, thrombosis, and vascular biology. 2010;30:1725-1732
76. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent tgf-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. The Journal of cell biology.
1990;111:757-763
77. Gerhardt H, Wolburg H, Redies C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Developmental dynamics:
an official publication of the American Association of Anatomists.
2000;218:472-479
78. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis.
Cell and tissue research. 2003;314:15-23
79. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nature protocols.
2007;2:481-485
80. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967
81. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:3422-3427
82. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S.
Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation. 2003;108:2511-2516
83. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, thrombosis, and vascular biology. 2004;24:288-293
84. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.
Blood. 2004;104:2752-2760
85. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circulation research. 2012;110:624-637
86. Asahara T, Kawamoto A, Masuda H. Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells. 2011;29:1650-1655
87. Prasain N, Meador JL, Yoder MC. Phenotypic and functional characterization of endothelial colony forming cells derived from human umbilical cord blood.
Journal of visualized experiments : JoVE. 2012
88. Xue S, Zhang HT, Zhang P, Luo J, Chen ZZ, Jang XD, Xu RX. Functional endothelial progenitor cells derived from adipose tissue show beneficial effect on cell therapy of traumatic brain injury. Neuroscience letters. 2010;473:186-191
89. Jantzen AE, Lane WO, Gage SM, Jamiolkowski RM, Haseltine JM, Galinat LJ, Lin FH, Lawson JH, Truskey GA, Achneck HE. Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model. Biomaterials. 2011;32:8356-8363
90. Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B. The angiogenic factor ccn1 promotes adhesion and migration of circulating cd34+
progenitor cells: Potential role in angiogenesis and endothelial regeneration.
Blood. 2007;110:877-885
91. Fataccioli V, Abergel V, Wingertsmann L, Neuville P, Spitz E, Adnot S, Calenda V, Teiger E. Stimulation of angiogenesis by cyr61 gene: A new therapeutic candidate. Human gene therapy. 2002;13:1461-1470
92. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. Cyr61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor
growth. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:6355-6360
93. Jun JI, Lau LF. The matricellular protein ccn1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nature cell biology.
2010;12:676-685
94. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of cyr61 (ccn1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. The Journal of biological chemistry. 2002;277:46248-46255
95. Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, Lau LF. The angiogenic factor cysteine-rich 61 (cyr61, ccn1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology. 2002;143:1441-1450
96. Grzeszkiewicz TM, Kirschling DJ, Chen N, Lau LF. Cyr61 stimulates human skin fibroblast migration through integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. The Journal of biological chemistry. 2001;276:21943-21950
97. Yu Y, Gao Y, Qin J, Kuang CY, Song MB, Yu SY, Cui B, Chen JF, Huang L.
Ccn1 promotes the differentiation of endothelial progenitor cells and reendothelialization in the early phase after vascular injury. Basic research in cardiology. 2010;105:713-724
98. Yu Y, Gao Y, Wang H, Huang L, Qin J, Guo R, Song M, Yu S, Chen J, Cui B, Gao P. The matrix protein ccn1 (cyr61) promotes proliferation, migration and tube formation of endothelial progenitor cells. Experimental cell research.
2008;314:3198-3208
99. Bar A, Dorfman SE, Fischer P, Hilfiker-Kleiner D, Cebotari S, Tudorache I, Suprunov M, Haverich A, Hilfiker A. The pro-angiogenic factor ccn1 enhances
the re-endothelialization of biological vascularized matrices in vitro.
Cardiovascular research. 2010;85:806-813
100. Hopkins RA, Jones AL, Wolfinbarger L, Moore MA, Bert AA, Lofland GK.
Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. The Journal of thoracic and cardiovascular surgery. 2009;137:907-913, 913e901-904
101. Leyh R, Wilhelmi M, Haverich A, Mertsching H. [a xenogeneic acellularized matrix for heart valve tissue engineering: In vivo study in a sheep model].
Zeitschrift fur Kardiologie. 2003;92:938-946
102. De Visscher G, Blockx H, Meuris B, Van Oosterwyck H, Verbeken E, Herregods MC, Flameng W. Functional and biomechanical evaluation of a completely recellularized stentless pulmonary bioprosthesis in sheep. The Journal of thoracic and cardiovascular surgery. 2008;135:395-404
103. Quinn RW, Hilbert SL, Bert AA, Drake BW, Bustamante JA, Fenton JE, Moriarty SJ, Neighbors SL, Lofland GK, Hopkins RA. Performance and morphology of decellularized pulmonary valves implanted in juvenile sheep.
The Annals of thoracic surgery. 2011;92:131-137
104. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: Advanced studies of a bioengineered xeno-autograft. The Annals of thoracic surgery. 2000;70:1962-1969
105. Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep. The Journal of thoracic and cardiovascular surgery. 1994;108:880-887
106. Paliwal P, Pishesha N, Wijaya D, Conboy IM. Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration. Aging. 2012;4:553-566
107. Zhang X, Sarkar K, Rey S, Sebastian R, Andrikopoulou E, Marti GP, Fox-Talbot K, Semenza GL, Harmon JW. Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds. J Mol Med (Berl). 2011;89:985-995
108. Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging.
Circulation research. 2012;110:1109-1124
109. Madonna R, De Caterina R, Willerson JT, Geng YJ. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. European heart journal. 2011;32:1190-1196
110. Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V. Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation.
2011;123:1650-1660
111. Alt EU, Senst C, Murthy SN, Slakey DP, Dupin CL, Chaffin AE, Kadowitz PJ, Izadpanah R. Aging alters tissue resident mesenchymal stem cell properties.
Stem cell research. 2012;8:215-225
112. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood.
2007;109:1801-1809
113. Braun M. Histologische Untersuchung Dezellularisierter Aortenklappenmatrices nach orthotoper Implantation ins Schafmodell.
Hannover, Institut für Pathologie, Diss. 2011
114. Calistru A TI, Tudorache G., Cebotari S., Haverich A., Hilfiker A. Epc derived endothelial cells serve for re-endothelialization of ovine decellularized pulmonary valves in vitro. The Thoracic and cardiovascular Surgeon, Supplement. 2009; 57:S61
115. Tudorache I, Calistru A, Baraki H, Meyer T, Hoffler K, Sarikouch S, Bara C, Hartung D, Gorler A, Hilfiker A, Haverich A, Cebotari S. Orthotopic replacement of aortic heart valves with tissue engineered grafts. Tissue engineering. Part A. 2013
116. Small J, Rottner K, Hahne P, Anderson KI. Visualising the actin cytoskeleton.
Microscopy research and technique. 1999;47:3-17
117. Beckstead JH. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1994;42:1127-1134
118. Teshima H, Hayashida N, Yano H, Nishimi M, Tayama E, Fukunaga S, Akashi H, Kawara T, Aoyagi S. Obstruction of st jude medical valves in the aortic position: Histology and immunohistochemistry of pannus. The Journal of thoracic and cardiovascular surgery. 2003;126:401-407
119. Breugelmans S, De Spiegelaere W, Casteleyn C, Simoens P, Van den Broeck W. Differences between the ovine tonsils based on an immunohistochemical quantification of the lymphocyte subpopulations. Comparative immunology, microbiology and infectious diseases. 2011;34:217-225
120. Gabbiani G, Kapanci Y, Barazzone P, Franke WW. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. The American journal of pathology.
1981;104:206-216
121. Franke WW, Schmid E, Osborn M, Weber K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proceedings of the National Academy of Sciences of the United States of America.
1978;75:5034-5038
122. Galmiche G, Labat C, Mericskay M, Aissa KA, Blanc J, Retailleau K, Bourhim M, Coletti D, Loufrani L, Gao-Li J, Feil R, Challande P, Henrion D, Decaux JF, Regnault V, Lacolley P, Li Z. Inactivation of serum response factor contributes to decrease vascular muscular tone and arterial stiffness in mice. Circulation research. 2013;112:1035-1045
123. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664
124. Liu J, Liu Y, Xu Y, Wang M, Zhu Q, Li W, Wang X, Liu J, Ma B, Wu K.
Neurotransmitter noradrenaline downregulate cytoskeletal protein expression of vsmcs. Experimental and molecular pathology. 2013;94:79-83
125. Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, Williams JM,
125. Hubbell MC, Semotiuk AJ, Thorpe RB, Adeoye OO, Butler SM, Williams JM,